| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |